Clinical Screening Tools for Sarcopenia and Its Management
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Sarcopenia, an age-related decline in muscle mass and function, is affecting the older population worldwide. Sarcopenia is associated with poor health outcomes, such as falls, disability, loss of independence, and mortality; however it is potentially treatable if recognized and intervened early. Over the last two decades, there has been significant expansion of research in this area. Currently there is international recognition of a need to identify the condition early for intervention and prevention of the disastrous consequences of sarcopenia if left untreated. There are currently various screening tools proposed. As yet, there is no consensus on the best tool. Effective interventions of sarcopenia include physical exercise and nutrition supplementation. This review paper examined the screening tools and interventions for sarcopenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HASKELL, W. L., LEE, I.-M., PATE, R. R., POWELL, K. E., BLAIR, S. N., FRANKLIN, B. A., MACERA, C. A., HEATH, G. W., THOMPSON, P. D., & BAUMAN, A. (2007) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3180616b27 · Cited by 4,616 · cited 1×
“Daily muscle protein turnover is regulated in large part by nutrition, especially dietary protein [41].”
BackgroundProgression Models in Resistance Training for Healthy Adults
(2009) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181915670 · Cited by 4,332 · cited 1×
“Pharmaceutical agents are still under investigation with no clear evidence of benefit yet.”
BackgroundProgression Models in Resistance Training for Healthy Adults
(2002) · Medicine and Science in Sports and Exercise · doi:10.1097/00005768-200202000-00027 · Cited by 2,979
Bauer, J., Biolo, G., Cederholm, T., Cesari, M., Cruz-Jentoft, A. J., Morley, J. E., Phillips, S., Sieber, C., Stehle, P., Teta, D., et al. (2013) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.05.021 · Cited by 2,553 · cited 2×
“Evidence shows that resistance exercise increases muscle protein synthesis in the elderly at all protein doses, but to a greater extent with higher protein doses of 40 g [49].”
BackgroundSelf-citationNELSON, M. E., REJESKI, W. J., BLAIR, S. N., DUNCAN, P. W., JUDGE, J. O., KING, A. C., MACERA, C. A., & CASTANEDA-SCEPPA, C. (2007) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3180616aa2 · Cited by 2,089
Cruz-Jentoft, A. J., Landi, F., Schneider, S. M., Zuniga, C., Arai, H., Boirie, Y., Chen, L.-K., Fielding, R. A., Martin, F. C., Michel, J.-P., et al. (2014) · Age and Ageing · doi:10.1093/ageing/afu115 · Cited by 1,963
Deutz, N. E. P., Bauer, J. M., Barazzoni, R., Biolo, G., Boirie, Y., Bosy-Westphal, A., Cederholm, T., Cruz-Jentoft, A., Krznariç, Z., Nair, K. S., et al. (2014) · Clinical Nutrition · doi:10.1016/j.clnu.2014.04.007 · Cited by 1,738
The healthcare costs of sarcopenia in the United States
Janssen, I., Shepard, D. S., Katzmarzyk, P. T., & Roubenoff, R. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52014.x · Cited by 1,546
SARC-F: A simple questionnaire to rapidly diagnose sarcopenia
Malmstrom, T. K., & Morley, J. E. (2013) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.05.018 · Cited by 1,319 · cited 3×
“SARC-F questionnaire [20] Uses 5 questions without requiring measurements involving cutoff values They have comparable specificity and predictive power for adverse outcomes when validated against criteria requiring measurements developed by consensus panels (American, European, and Asian).”
BackgroundMethodInfluentialSarcopenia as a risk factor for falls in elderly individuals: results from the ilSIRENTE study
Landi, F., Liperoti, R., Russo, A., Giovannini, S., Tosato, M., Capoluongo, E., Bernabei, R., & Onder, G. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2012.02.007 · Cited by 938
Beaudart, C., Buckinx, F., Rabenda, V., Gillain, S., Cavalier, E., Slomian, J., Petermans, J., Reginster, J.-Y., & Bruyère, O. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1742 · Cited by 676 · cited 1×
“Many pharmacological agents such as myostatin inhibitor, testosterone, and angiotensin converting enzyme inhibitors and ghrelin-modulating agents are being investigated to treat sarcopenia but there is inadequate evidence to support their use in mainstream practice [50].”
BackgroundNutritional recommendations for the management of sarcopenia
Morley, J. E., Argiles, J. M., Evans, W. J., Bhasin, S., Cella, D., Deutz, N. E. P., Doehner, W., Fearon, K. C. H., Ferrucci, L., Hellerstein, M. K., et al. (2010) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2010.04.014 · Cited by 664
Age-Associated Loss of Power and Strength in the Upper Extremities in Women and Men
Metter, E. J., Conwit, R., Tobin, J., & Fozard, J. L. (1997) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/52a.5.b267 · Cited by 592
Tieland, M., Dirks, M. L., van der Zwaluw, N., Verdijk, L. B., van de Rest, O., de Groot, L. C. P. G. M., & van Loon, L. J. C. (2012) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2012.05.020 · Cited by 556
Kim, H. K., Suzuki, T., Saito, K., Yoshida, H., Kobayashi, H., Kato, H., & Katayama, M. (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2011.03776.x · Cited by 551
Grimby, G., & Saltin, B. (1983) · Clinical Physiology · doi:10.1111/j.1475-097x.1983.tb00704.x · Cited by 513 · cited 1×
“Muscle mass is lost at a rate of approximately 8% per decade from the age of 50 years until the age of 70 years, after which weight loss is coupled with an accelerated loss of muscle mass, reaching a rate of 15% per decade [2].”
BackgroundYang, Y., Breen, L., Burd, N. A., Hector, A. J., Churchward-Venne, T. A., Josse, A. R., Tarnopolsky, M. A., & Phillips, S. M. (2012) · British Journal of Nutrition · doi:10.1017/s0007114511007422 · Cited by 480 · cited 1×
“The use of biomarkers in screening for sarcopenia requires further investigation.”
BackgroundValidating the SARC-F: A Suitable Community Screening Tool for Sarcopenia?
Woo, J., Leung, J., & Morley, J. E. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2014.04.021 · Cited by 422
Control of the size of the human muscle mass
Rennie, M. J., Wackerhage, H., Spangenburg, E. E., & Booth, F. W. (2004) · Annual Review of Physiology · doi:10.1146/annurev.physiol.66.052102.134444 · Cited by 399 · cited 1×
“There is evidence that resistance exercise combined with protein supplementation leads to greater muscle mass gain compared to resistance exercise or protein supplementation alone [47].”
BackgroundSarcopenia and Mortality among Older Nursing Home Residents
Landi, F., Liperoti, R., Fusco, D., Mastropaolo, S., Quattrociocchi, D., Proia, A., Tosato, M., Bernabei, R., & Onder, G. (2012) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2011.07.004 · Cited by 344 · cited 1×
“Sarcopenia, an age-related decline inmusclemass and function, is affecting the older populationworldwide.”
BackgroundSkeletal Muscle Hypertrophy After Aerobic Exercise Training
Konopka, A. R., & Harber, M. P. (2014) · Exercise and Sport Sciences Reviews · doi:10.1249/jes.0000000000000007 · Cited by 320 · cited 1×
“It has also beneficial impact on sarcopenia by improving skeletal muscle insulin sensitivity; stimulating skeletal muscle hypertrophy; and increasing skeletal muscle mass [24, 37].”
BackgroundBiolo, G., De Cicco, M., Dal Mas, V., Lorenzon, S., Antonione, R., Ciocchi, B., Barazzoni, R., Zanetti, M., Dore, F., & Guarnieri, G. (2006) · Nutrition · doi:10.1016/j.nut.2005.11.003 · Cited by 26
Cited by
Cruz-Jentoft, A. J., & Sayer, A. A. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31138-9 · Cited by 3,905
Association Between Sarcopenia and Cognitive Impairment: A Systematic Review and Meta-Analysis
Chang, K.-V., Hsu, T.-H., Wu, W.-T., Huang, K.-C., & Han, D.-S. (2016) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2016.09.013 · Cited by 448
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Eichorst, B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s005 · Cited by 305
Skeletal muscle aging: influence of oxidative stress and physical exercise
Gomes, M. J., Martinez, P. F., Pagan, L. U., Damatto, R. L., Mariano Cezar, M. D., Ruiz Lima, A. R., Okoshi, K., & Okoshi, M. P. (2017) · Oncotarget · doi:10.18632/oncotarget.14670 · Cited by 285
SARC-F for Screening of Sarcopenia Among Older Adults: A Meta-analysis of Screening Test Accuracy
Ida, S., Kaneko, R., & Murata, K. (2018) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2018.04.001 · Cited by 265
Metadata
- Authors
- Yu, S. C. Y., Khow, K. S. F., Jadczak, A. D., & Visvanathan, R.
- Venue
- Current Gerontology and Geriatrics Research
- Publisher
- Hindawi Limited
- Published
- 2016
- Volume
- 2016
- Pages
- 1-10
- ISSN
- 1687-7063 (ISSN-L)
- 1687-7071
- OpenAlex
- W2253336578
- Cited by
- 84
- References
- 22
- FWCI
- 6.62
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.